Laser Treatment for Vision Loss from Branch Retinal Vein Occlusion is Safer Than Corticosteroid Injections and Equally Effective
September 14, 2009
September 14, 2009
WASHINGTON, Sept. 14 -- The U.S. Department of Health & Human Services' National Institutes of Health issued the following news release:
Scientists have found that laser therapy is equivalent to two different dosages of corticosteroid medications for treating vision loss from the blockage of small veins in the back of the eye, a condition known as branch retinal vein occlusion (BRVO). Furthermore, laser treatment was shown to have fewer complications for patients.
Scientists have found that laser therapy is equivalent to two different dosages of corticosteroid medications for treating vision loss from the blockage of small veins in the back of the eye, a condition known as branch retinal vein occlusion (BRVO). Furthermore, laser treatment was shown to have fewer complications for patients.